Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis
- PMID: 38843133
- PMCID: PMC11389564
- DOI: 10.1164/rccm.202310-1887OC
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis
Abstract
Rationale: Accelerated biological aging has been implicated in the development of interstitial lung disease (ILD) and other diseases of aging but remains poorly understood. Objectives: To identify plasma proteins that mediate the relationship between chronological age and survival association in patients with ILD. Methods: Causal mediation analysis was performed to identify plasma proteins that mediated the chronological age-survival relationship in an idiopathic pulmonary fibrosis discovery cohort. Proteins mediating this relationship after adjustment for false discovery were advanced for testing in an independent ILD validation cohort and explored in a chronic obstructive pulmonary disease cohort. A proteomic-based measure of biological age was constructed and survival analysis performed, assessing the impact of biological age and peripheral blood telomere length on the chronological age-survival relationship. Measurements and Main Results: Twenty-two proteins mediated the chronological age-survival relationship after adjustment for false discovery in the idiopathic pulmonary fibrosis discovery cohort (n = 874), with 19 remaining significant mediators of this relationship in the ILD validation cohort (n = 983) and one mediating this relationship in the chronic obstructive pulmonary disease cohort. Latent transforming growth factor-β binding protein 2 and ectodysplasin A2 receptor showed the strongest mediation across cohorts. A proteomic measure of biological age completely attenuated the chronological age-survival association and better discriminated survival than chronological age. Results were robust to adjustment for peripheral blood telomere length, which did not mediate the chronological age-survival relationship. Conclusions: Molecular measures of aging completely mediate the relationship between chronological age and survival, suggesting that chronological age has no direct effect on ILD survival.
Keywords: age; causal mediation; idiopathic pulmonary fibrosis; proteomics.
Figures



Comment in
-
Unveiling Biological Age: A New Frontier in Predicting Outcomes in Chronic Lung Disease.Am J Respir Crit Care Med. 2024 Sep 1;210(5):541-543. doi: 10.1164/rccm.202407-1290ED. Am J Respir Crit Care Med. 2024. PMID: 39078175 Free PMC article. No abstract available.
References
-
- Jo HE, Randhawa S, Corte TJ, Moodley Y. Idiopathic pulmonary fibrosis and the elderly: diagnosis and management considerations. Drugs Aging . 2016;33:321–334. - PubMed
-
- Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med . 2003;167:962–969. - PubMed
-
- Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med . 2012;156:684–691. - PubMed
MeSH terms
Substances
Grants and funding
- U24 HL141762/HL/NHLBI NIH HHS/United States
- K23 HL146942/HL/NHLBI NIH HHS/United States
- K23HL148498/HL/NHLBI NIH HHS/United States
- R01HL169166/HL/NHLBI NIH HHS/United States
- UG3HL145266/HL/NHLBI NIH HHS/United States
- K23HL150301/HL/NHLBI NIH HHS/United States
- R01 HL166290/HL/NHLBI NIH HHS/United States
- HHSN268200900016C/HL/NHLBI NIH HHS/United States
- K23HL146942/HL/NHLBI NIH HHS/United States
- K23 HL150301/HL/NHLBI NIH HHS/United States
- HHSN268200900014C/HL/NHLBI NIH HHS/United States
- RO1HL130796/HL/NHLBI NIH HHS/United States
- R01 HL144718/HL/NHLBI NIH HHS/United States
- T32 HL007749/HL/NHLBI NIH HHS/United States
- HHSN268200900019C/HL/NHLBI NIH HHS/United States
- R01 HL130796/HL/NHLBI NIH HHS/United States
- HHSN268200900015C/HL/NHLBI NIH HHS/United States
- U01 HL137880/HL/NHLBI NIH HHS/United States
- K23 HL148498/HL/NHLBI NIH HHS/United States
- HHSN268200900018C/HL/NHLBI NIH HHS/United States
- R01 HL169166/HL/NHLBI NIH HHS/United States
- HHSN268200900017C/HL/NHLBI NIH HHS/United States
- HHSN268200900020C/HL/NHLBI NIH HHS/United States
- UG3 HL145266/HL/NHLBI NIH HHS/United States
- HHSN268200900013C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical